TH9507

Description

What is TH9507?

TH9507 is a stabilized synthetic analogue of Growth Hormone Releasing Hormone (GHRH). It has been studied for its role in reducing visceral adipose tissue in clinical research that involves HIV-associated lipodystrophy.

Lipodystrophy is a metabolic condition often associated with insulin resistance, fat redistribution, and hyperlipidemia associated with antiretroviral therapy for the treatment of HIV infection.

Chemical and Molecular Properties of TH9507

CAS Number	218949-48-5
Molecular Formula	C221H366N72O67S
Molecular Weight	5136 g/mol
Synonyms	TH9507, TH 9507, tesamorelina, tesamorelinum
Purity	99%
Storage	2-8°C (35-46°F)

TH9507's Mechanism of Action

TH9507 works by mimicking the natural Growth Hormone Releasing Hormone, stimulating the pituitary gland to release more growth hormone. This increase in growth hormone has been evaluated in clinical studies for its effects on metabolic parameters and visceral adipose tissue.

Binding to GHRH receptors has been observed in clinical studies to assess its effect on growth hormone secretion and visceral adipose tissue measurements.

Clinical research on TH9507

Several studies have shown that TH9507 is effective in various ways. The majority of clinical research shows that TH9507 is associated with changes in visceral adipose tissue among individuals with HIV-associated lipodystrophy.

TH9507 is FDA-approved for the treatment of HIV-associated lipodystrophy, but other potential uses are still under research.

TH9507 and Lipodystrophy

Lipodystrophy is a medical condition characterized by insulin resistance and fat redistribution in patients who are HIV-positive.

TH9507 is mainly known for its effect on fat loss. Clinical studies reported reductions in visceral adipose tissue among participants with HIV-associated lipodystrophy.[R]

TH9507 and Cognition

Studies show that TH9507 has shown promising results in improving cognitive health. Growth hormone may have neuroprotective effects, but the exact mechanism and extent are still being studied.

While research is still going on, TH9507 shows promise in improving cognitive function, but more research is required before making assumptions.

TH9507 and Muscle Mass

With increasing age, the levels of growth hormones naturally decline in the body, leading to increased fat mass and reduced muscle mass.

It has been studied for its effects on growth hormone levels and lean body mass measurements. [R]

Note: TH9507 is approved by the FDA under the brand name of Egrifta. The approval is limited specifically to HIV-associated lipodystrophy.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. THE PRODUCTS DESCRIBED HEREIN ARE FOR LABORATORY AND RESEARCH USE ONLY. All clinical research must be conducted with oversight from the appropriate Institutional Review Board (IRB). All preclinical research must be conducted with oversight from the appropriate Institutional Animal Care and Use Committee (IACUC) following the guidelines of the Animal Welfare Act (AWA).

Our content is intended to be used and must be used for informational purposes only. It is very important to do your own analysis and research from Trusted Sources before making any purchase, based on your personal circumstances. You should independently research and verify any information that you find on our Website and wish to rely upon.

By completing and paying for your order, you agree to our Terms and Conditions. Customer satisfaction is our number one priority. If you are not 100% satisfied with the product you received, please contact us at support@purerawz.co

ATTENTION: All our products are for LABORATORY AND RESEARCH PURPOSES ONLY, not for veterinary or human usage.